Single in usion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine

Pediatric Nephrology

Volumn 25, Issue 3, 2010, Pages 539-544

  Fujinaga, Shuichiro ^a   Irano, Daishi ^a   Nishizaki, Naoto ^a   Kamei, Koichi ^b   To, Shuichi ^b   Ohtomo, Yoshiyuki ^c   Shimizu, Toshiaki ^d   Kaneko, Kazunari ^e  

^a SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^b NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c JUNTENDO UNIVERSITY NERIMA HOSPITAL   (Japan)

^d JUNTENDO UNIVERSITY   (Japan)

^e KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cyclosporine; Minimal change disease; Rituximab; Steroid dependent nephrotic syndrome

Indexed keywords

CD19 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPHENHYDRAMINE; IMMUNOSUPPRESSIVE AGENT; MIZORIBINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARACETAMOL; PREDNISOLONE; RITUXIMAB; ANTIINFLAMMATORY AGENT; CYCLOSPORIN; MONOCLONAL ANTIBODY; STEROID;

ADOLESCENT; ARTICLE; BACTERIAL INFECTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FLUSHING; HOSPITALIZATION; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN DEFICIENCY; INFANT; KIDNEY BIOPSY; LYMPHOCYTE DEPLETION; MAINTENANCE THERAPY; MALAISE; MALE; MULTIPLE CYCLE TREATMENT; NEPHROTIC SYNDROME; NEPHROTOXICITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEINURIA; RELAPSE; SCHOOL CHILD; SIDE EFFECT; SINGLE DRUG DOSE; STEROID DEPENDENT NEPHROTIC SYNDROME; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE; DRUG RESISTANCE; FOLLOW UP; IMMUNOLOGY; LIPOID NEPHROSIS; LYMPHOCYTE; RECURRENT DISEASE; TREATMENT OUTCOME;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD19; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LYMPHOCYTES; MALE; NEPHROSIS, LIPOID; PREDNISOLONE; RECURRENCE; STEROIDS; TREATMENT OUTCOME;

EID: 77950362581     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-009-1377-5     Document Type: Article

References (20)

1. Hodson EM, Alexander SI (2008) Evaluation and management of steroid-sensitive nephrotic syndrome. Curr Opin Pediatr 20:145-150 (Pubitemid 351365703)
2. Kyrieleis HA, Levtchenko EN, Wetzels JF (2007) Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome. Am J Kidney Dis 49:592-597 (Pubitemid 46654498)
3. Okada M, Sugimoto K, Yagi K, Yanagida H, Tabata N, Takemura T (2007) Mycophenolate mofetil therapy for children with intractable nephrotic syndrome. Pediatr Int 49:933-937 (Pubitemid 350197148)
4. Benz K, D̈tsch J, Rascher W, Stachel D (2004) Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy. Pediatr Nephrol 19:794-797 (Pubitemid 38931165)
5. Smith GC (2007) Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome? Pediatr Nephrol 22:893-898 (Pubitemid 46629628)
6. Gilbert RD, Hulse E, Rigden S (2006) Rituximab therapy for steroid-dependent minimal change nephrotic syndrome. Pediatr Nephrol 21:1698-1700 (Pubitemid 44390835)
7. Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, Groothoff J, Llanas B, Niaudet P, Nivet H, Raynaud N, Taque S, Ronco P, Bouissou F (2008) Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol 23:1269-1279
8. Kamei K, Ito S, Nozu K, Fujinaga S, Nakayama M, Sako M, Saito M, Yoneko M, Iijima K (2009) Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children. Pediatr Nephrol 24:1321-1328
9. Fujinaga S, Kaneko K, Muto T, Ohtomo Y, Murakami H, Yamashiro Y (2006) Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome. Arch Dis Child 91:666-670 (Pubitemid 44197108)
10. Fujinaga S, Kaneko K, Takada M, Ohtomo Y, Akashi S, Yamashiro Y (2005) Preprandial C2 monitoring of cyclosporine treatment in children with nephrotic syndrome. Pediatr Nephrol 20:1359-1360 (Pubitemid 41222991)
11. Fujinaga S, Ohtomo Y, Umino D, Takemoto M, Shimizu T, Yamashiro Y, Kaneko K (2007) A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome. Pediatr Nephrol 22:71-76 (Pubitemid 46138363)
12. Komiya H, Masubuchi Y, Mori Y, Tajima N (2008) The validity of body mass index criteria in obese school-age children. Tohoku J Exp Med 214:27-37 (Pubitemid 351176314)
13. Shalhoub RJ (1974) Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 2:556-560
14. Grimbert P, Audard V, Remy P, Lang P, Sahali D (2003) Recent approaches to the pathogenesis of minimal-change nephrotic syndrome. Nephrol Dial Transplant 18:245-248 (Pubitemid 36181671)
15. Kemper MJ, Meyer-Jark T, Lilova M, Müller-Wiefel DE (2003) Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome. Clin Nephrol 60:242-247 (Pubitemid 37258847)
16. Haffner D, Fischer DC (2009) Nephrotic syndrome and rituximab: facts and perspectives. Pediatr Nephrol 24:1433-1438
17. François H, Daugas E, Bensman A, Ronco P (2007) Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations. Am J Kidney Dis 49:158-161 (Pubitemid 44932200)
18. D̈tsch J, Müller-Wiefel DE, Kemper MJ (2008) Rituximab: is replacement of cyclophosphamide and calcineurin inhibitors in steroid-dependent nephrotic syndrome possible? Pediatr Nephrol 23:3-7
19. Sharma AP, Filler G (2009) Role of mycophenolate mofetil in remission maintenance after a successful response to rituximab. Pediatr Nephrol 24:423-424
20. Bagga A, Sinha A, Moudgil A (2007) Rituximab in patients with the steroid-resistant nephrotic syndrome. N Engl J Med 356:2751-2752 (Pubitemid 47001064)